A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- P-One Clinic
Hachiōji, Japan
Kenichi FurihataRecruiting - Oita University Hospital
Yufu, Japan
Naoto UemuraRecruiting
- Collaborative Neuroscience Network - Cns
Los Alamitos, California, United States
Steven ReynoldsRecruiting - Collaborative Neuroscience Network - Cns
Los Alamitos, California, United States
Omid OmidvarRecruiting - K2 Medical Research, Llc
Maitland, Florida, United States
Completed - Aqualane Clinical Research
Naples, Florida, United States
William JustizRecruiting - Charter Research
Orlando, Florida, United States
Diana BalsalobreRecruiting - Progressive Medical Research
Port Orange, Florida, United States
Alexander WhiteRecruiting - Charter Research
The Villages, Florida, United States
Jeffrey NortonRecruiting - K2 Medical Research, Llc
The Villages, Florida, United States
Craig CurtisRecruiting - Quest Research Institute
Farmington Hills, Michigan, United States
Aaron EllenbogenRecruiting - Ppd Development, Lp
Austin, Texas, United States
Sabrina MerchantRecruiting - Not, yet, recruiting
- Inland Northwest Research
Spokane, Washington, United States
Jason AldredNot, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Feb 2025
- Primary completion
- 31 Jan 2028
- Completion
- 31 Jan 2028
- Last update posted
- 20 Apr 2026
- Registered enrollment
- 127
- Registry id
- NCT06809400
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.